Vertex Pharmaceuticals Increase (Decrease) in Inventories increased by 26.2% to $97.70M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 41.5%, from $167.10M to $97.70M. Over 4 years (FY 2021 to FY 2025), Increase (Decrease) in Inventories shows an upward trend with a 54.2% CAGR.
An increase may signal expected demand growth or supply chain bottlenecks, while a decrease might indicate strong sales or inventory optimization efforts.
Represents the net change in the value of raw materials, work-in-progress, and finished goods held by the company. This...
Standard metric for manufacturing and industrial firms; essential for evaluating inventory turnover and operational health.
other_increase_decrease_in_inventories| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $24.70M | $18.30M | $27.00M | -$2.00M | $33.30M | $26.80M | $78.30M | $80.73M | $80.73M | $80.73M | $80.73M | $80.10M | $107.20M | $182.50M | $147.50M | $167.10M | $148.60M | $131.10M | $77.40M | $97.70M |
| QoQ Change | — | -25.9% | +47.5% | -107.4% | >999% | -19.5% | +192.2% | +3.1% | +0.0% | +0.0% | +0.0% | -0.8% | +33.8% | +70.2% | -19.2% | +13.3% | -11.1% | -11.8% | -41.0% | +26.2% |
| YoY Change | — | — | — | — | +34.8% | +46.4% | +190.0% | >999% | +142.4% | +201.2% | +3.1% | -0.8% | +32.8% | +126.1% | +82.7% | +108.6% | +38.6% | -28.2% | -47.5% | -41.5% |